期刊文献+

全球化妆品非动物测试法规进程及国内现状 被引量:1

Progress of global regulations on cosmetic non-animal testing and domestic status
下载PDF
导出
摘要 综述了国内外化妆品非动物测试法规进程及发展趋势。主要从法规政策变革,替代方法的开发及法规采纳几个方面对比了国内外的最新进展,详细分析了我国化妆品非动物测试相关政策及替代方法采纳进程,展望了化妆品行业体外替代方法发展趋势。最后指出发展化妆品非动物测试方法是我国化妆品产业链升级和市场分化的重要契机,未来将迎来安全评价模式变迁,全球协同市场迅速发展及品牌建设新概念的新态势。 The process and development trend of non-animal testing regulations of cosmetics both at home and abroad had been reviewed. The global and domestic progresses were compared in the aspects of the regulation & policy changes, the development of alternative methods and the regulatory adoption. The process of relevant policy changes and alternative adoption in China on non- animal testing had been analyzed in detail. Then the future trend of in vitro alternative methods in cosmetic industry was prospected. It had been pointed out that the development of cosmetic non-animal testing methods would be a critical opportunity for upgrading and market differentiation for the Chinese cosmetic industry. The future market will encounter the evolution of safety evaluation paradigm, the booming in global coherent market and the new concept on brand building.
作者 瞿小婷 程树军 QU Xiao-tinga;CHENG Shu-jun(Guangzhou Chn-Alternative Biotechnology Co. Ltd, Guangzhou, Guangdong 510535, China;Guangdong Inspection and Quarantine Technology Center, Guangzhou, Guangdong 510642, China)
出处 《日用化学品科学》 CAS 2017年第12期1-9,共9页 Detergent & Cosmetics
关键词 非动物测试 替代方法 化妆品 毒性试验 法规 non-animal testing alternative method cosmetics toxicity test regulation
  • 相关文献

参考文献2

二级参考文献30

  • 1MICHAELBALLS.3R和仁慈准则[M].程树军,译北京:科学出版社,2010.
  • 2KREWSKI D, ACOSTA D, ANDERSEN M, et al. Toxicity testing in the 21st century: a vision and a strategy[J]. Toxicol Environ Health B Crit Rev, 2010, 13: 51-138.
  • 3Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes[K]. Off J Eur Communities, 2010, L276: 33-79.
  • 4MOORE NP, ANDREW DJ, BJERKE DL, et al. Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) [J]. Regulatory Toxicology and Pharmacology, 2013, 66(1): 30-37.
  • 5SEIDLE T, PRIETO P, BULGHERONI A. Examining the regulatory value of multi-route mammalian acute systemic toxicity studies[J]. Alternatives to Animal Experimentation, 2011, 28(2): 95-102.
  • 6ROBINSON S, DELONGEAS JL, DONALD E, et al. European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development[J]. Regul Toxicol Pharmacol, 2008, 50: 345-352.
  • 7EURL ECVAM status report on the development, validation and regulatory acceptance of alternative methods and approaches[R]. JRC Science and Policy Report, 2015.
  • 8OECD. The Adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins, part 2: use of the AOP to develop chemical categories and integrated assessment and testing approaches[K]. Series on Testing and Assessment No. 168, 2012.
  • 9RAMIREZ T, MEHLING A, KOLLE SN, et al. LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification [J]. Toxicol In Vitro, 2014, 28(8): 1482-97.
  • 10The SCCS notes of guidance for the testing of cosmetic ingredients and their safety evaluation[K]. 2015.

共引文献20

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部